PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis.
The expression of Programmed cell Death Ligand 1 (PD-L1) is observed in many malignant tumors and is associated with poor prognosis including Gastric Cancer (GC). The relationship between PD-L1 expression and prognosis, however, is controversial in GC. This paper purports to use a meta-analysis to i...
Saved in:
| Main Authors: | Lihu Gu, Manman Chen, Dongyu Guo, Hepan Zhu, Wenchao Zhang, Junhai Pan, Xin Zhong, Xinlong Li, Haoran Qian, Xianfa Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0182692 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neoadjuvant PD-1/PD-L1 inhibitors combined with chemotherapy in gastric cancer and gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis of single-arm studies
by: Jun Leng, et al.
Published: (2025-08-01) -
Lactylation-related gene signature accurately predicts prognosis and immunotherapy response in gastric cancer
by: Xuezeng Sun, et al.
Published: (2024-11-01) -
Radiomics-based biomarker for PD-1 status and prognosis analysis in patients with HCC
by: Gulizaina Hapaer, et al.
Published: (2025-01-01) -
Immunohistochemical‐Based Molecular Typing of ACRG Combined With Immune‐Associated PD‐L1 Expression Can Predict the Prognosis of Gastric Cancer
by: Fang Li, et al.
Published: (2025-04-01) -
Efficacy and Safety of PD-1/PD-L1 Inhibitors in Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
by: Zhen-Yu Li, et al.
Published: (2023-09-01)